What question did this study set out to answer?

To explore the effectiveness of transcatheter aortic valve replacement in patients with failed homografts.

March 22, 2026JACC Case Reports0 citationsOpen Access

Transcatheter Aortic Valve Replacement in a Failed Homograft

To explore the effectiveness of transcatheter aortic valve replacement in patients with failed homografts.
Discussion of TAVR devices designed specifically for aortic regurgitation (AR) treatment.
Analysis of the implications of commercial approval for TAVR devices.
TAVR is likely to become the preferred treatment option for patients with failed homografts after commercial approval.

Dedicated TAVR devices for AR will likely become the preferred treatment for failed homografts after commercial approval.

Perguntar à IA

Bookmark

View Full Paper

Reisinger et al. (Sun,) studied this question.

Perguntar à IA

Bookmark

View Full Paper